FDA 483 OBSERVATION · #172 OF 1,945 MOST-CITED

Buildings not maintained in good state of repair

FDA cited this observation 183 times across 171 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Drugs183
BY FISCAL YEAR
FY202617
FY202521
FY202419
FY202312
FY202214
FY202110
FY20207
FY201915
FY201825
FY201720
FY201623

What this observation is associated with

Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 4.3× the rate of the average FDA-cited firm (33.9% vs 7.8%), across 171 FEI-matched firms.

This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.

CHECKING ACCESS

Checking your access…

How FDA worded it — real examples

Buildings used in the manufacturing and processing of a drug product are not maintained in a good state of repair.

Aizant Drug Research Solutions Private Ltd. · Hyderabad · Drugs · 2026-07-31

Buildings used in the manufacturing, processing and holding of a drug product are not maintained in a good state of repair.

Inspec Solutions LLC · Holly Hill, Florida · Drugs · 2026-06-12

Buildings used in the manufacturing of a drug product are not maintained in a good state of repair.

Perrigo New York, Inc. · Bronx, New York · Drugs · 2026-05-08

Buildings used in the processing of a drug product are not maintained in a good state of repair.

Element Materials Technology Boston - Acton Inc. · Acton, Massachusetts · Drugs · 2026-05-04

Buildings used in the manufacturing and processing of a drug product are not maintained in a good state of repair.

GVS TM, Inc · Covina, California · Drugs · 2026-05-01

Buildings used in the holding of a drug product are not maintained in a good state of repair.

Granules Pharmaceuticals Inc. · Chantilly, Virginia · Drugs · 2026-04-03

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Pharma industry →

Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →